Blog
Disclosure Is Not Governance
AI disclosure is rising. Governance rituals are not. Boards need auditable oversight before filings become liabilities.
When Delegation Becomes Abdication
Vice Chancellor Laster refuses to dismiss breach claims against outside directors who rubber-stamped a fundamental transaction with no independent advisors — confirming delegation becomes abdication when boards abandon oversight entirely.
Biogen Closes Apellis Tender, Consolidating Complement Control Across GA and Nephrology
Biogen’s $5.6 billion tender offer for Apellis closes today, locking in two FDA-approved complement products and positioning the combined entity as the category incumbent in C3-mediated disease before rivals complete their own clinical programs.
The Compliance Clock
AI governance is becoming a calendar. Three dates, one board implication: build an auditable cadence before the deadline arrives.